Moritz Reese

6PUBLICATIONS

43CO-AUTHORS

Molecular targetsHaematological tumoursLiquid biopsiesPredictive and prognostic markers

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|Jun 15, 2026

Oncogenic KRAS-driven type I interferon signalling primes pancreatic cancer for necroptosis.

|Apr 23, 2026

Expression of cFLIP in B cells is essential for diffuse large B-cell lymphoma pathogenesis.

|Jan 26, 2026

Establishment and characterization of a CCND1-rearranged non-mantle cell lymphoma cell line and patient-derived xenograft model.

Claus-Moritz Gräf, Moritz Reese, Angela Vicente-Luque

|Nov 01, 2025

Redox destabilization by ibrutinib promotes ferroptosis in diffuse large B-cell lymphoma (DLBCL).

Anuschka Langpape, Debora Bonasera, Jenny Stroh

|Aug 29, 2024

Correction: Flammang et al. Tumor-Suppressive miR-192-5p Has Prognostic Value in Pancreatic Ductal Adenocarcinoma. <i>Cancers</i> 2020, <i>12</i>, 1693.

Isabelle Flammang, Moritz Reese, Anda J Ströse

|Jul 08, 2020

Tumor-Suppressive miR-192-5p Has Prognostic Value in Pancreatic Ductal Adenocarcinoma.

Isabelle Flammang, Moritz Reese, Anda J. Ströse

Pageof 1

Frequent Collaborators

Anda J. Ströse

Johannes A Eble

Silvia von Karstedt

Martin Peifer

Ron D Jachimowicz

Angela Vicente-Luque

Ferran Nadeu

Maria Latacz

Sílvia Beà

Elias Campo

Frequent Collaborators

Anda J. Ströse

Johannes A Eble

Silvia von Karstedt

Martin Peifer